Novo Nordisk

News

Lilly unveils promising data from dual-action diabetes drug

Eli Lilly’s investigational diabetes drug has shown early promise as a possible aid to overcoming obesity in trial results announced this week.

News

Novo to market 'connected' insulin pens next year

Novo Nordisk is to launch “connected” insulin pens, responding for demands from patients for devices able to communicate with glucose monitoring systems and glucose meters.

News

Novo to create California stem cell therapy manufacturing si...

Novo Nordisk has announced the establishment of a manufacturing site in Fremont, California, US to develop and produce stem cell-based therapies.

News

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Roche has bought immuno-oncology biotech firm Tusk Therapeutics for an upfront payment of £62 million.

News

Novo Nordisk lays off 400 staff in R&D shake-up

Novo Nordisk is laying off 400 people in Denmark and China so it can overhaul its R&D and speed up the expansion and diversification of products for serious chronic diseases.

News

Novo Nordisk CEO reassures UK patients over Brexit insulin s...

Novo Nordisk has doubled its insulin stockpile in the UK, amid patients' fears that a no-deal Brexit could disrupt supplies of the life-saving medicine, its CEO has said.

Lilly unveils promising data from dual-action diabetes drug

Novo to market 'connected' insulin pens next year

Novo to create California stem cell therapy manufacturing si...

Roche buys Tusk, plus cancer immunotherapy drug, for £62m

Novo Nordisk lays off 400 staff in R&D shake-up

Novo Nordisk CEO reassures UK patients over Brexit insulin s...

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Novo Nordisk

Editor's Picks